Disclosure notice: Skanditek's holding in Vitrolife is 29.9 percent

Disclosure notice: Skanditek's holding in Vitrolife is 29.9 percent Skanditek sold 1,000,000 shares in Vitrolife on December 18 with a view to reach a holding below 30 percent. Skanditek's ambition has been not to remain with a holding exceeding the take-over limit. Skanditek's holding in Vitrolife, after the transaction mentioned above, amounts to 5,495,700 shares, corresponding to 29.9 percent of the companies share capital and number of votes. Vitrolife is listed on the Stockholm Exchange's O list. Stockholm, December 19, 2003 SKANDITEK INDUSTRIFÖRVALTNING AB (publ) Patrik Tigerschiöld President For further information, contact: Patrik Tigerschiöld, President, phone +46 8 614 00 20, mobile +46 70 777 71 90, e-mail patrik.tigerschiold@skanditek.se Jonas Alfredson, Financial Manager, phone +46 (0)8 614 00 29, mobile +46 (0)733 904 912, e-mail jonas.alfredson@skanditek.se. Skanditek is an industrial holding company owning stock in Swedish companies. The business concept is to be an active and long-term stockholder and to further the portfolio companies' development by providing industrial and financial competence at board and management level. The portfolio comprises 12 companies within electronics, information technology, biotechnology and services. The major holdings are in Axis (14%), LGP Allgon (6%), MYDATA automation (39%), PartnerTech (40%) and Vitrolife (30%). Skanditek is listed on the Stockholm Exchange's O list. ------------------------------------------------------------ This information was brought to you by Waymaker http://www.waymaker.net The following files are available for download: http://www.waymaker.net/bitonline/2003/12/19/20040929BIT20400/wkr0001.pdf